For the osteoporosis-like phenotype GDD with low bone mass and low bone turnover, injectable PTH could be the best osteoanabolic treatment currently available for bone formation and activating WNT signaling in osteoblasts48,49. The gene discussed is PTH; the disease is osteoporosis.